{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:16:41Z","timestamp":1783549001140,"version":"3.55.0"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Gynecological disorders such as endometriosis, polycystic ovary syndrome, and gynecological cancers are increasingly recognized as potential risk factors for cardiovascular disease (CVD). Endometriosis, a chronic inflammatory condition, exhibits shared pathogenic mechanisms with CVD, including endothelial dysfunction and an atherogenic lipid profile. Emerging evidence suggests a link between endometriosis and an elevated risk of cardiovascular events such as myocardial infarction, ischemic heart disease, and hypertension. Polycystic ovary syndrome, characterized by hormonal imbalances and metabolic derangements, is associated with an increased risk of hypertension, myocardial infarction, and structural cardiac abnormalities, even after controlling for obesity. Gynecological cancers, such as ovarian, endometrial, and cervical cancers, are also associated with an increased burden of cardiovascular comorbidities and mortality. Cancer treatments, including chemotherapy and radiation therapy, can further contribute to cardiovascular toxicity. Understanding the interplay between gynecological disorders and CVD is crucial for identifying high-risk individuals, implementing preventive strategies, and providing comprehensive care. A multidisciplinary approach involving gynecologists, cardiologists, and other specialists is essential for optimizing the management of these complex conditions and improving overall patient outcomes.<\/jats:p>","DOI":"10.1097\/crd.0000000000000759","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:16:55Z","timestamp":1722345415000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Implications of Gynecological Disorders: Bridging the Gap Between Gynecology and Cardiology"],"prefix":"10.1097","author":[{"given":"Ashish","family":"Tripathi","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Arsha","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Thapa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universal College of Medical Sciences, Bhairhawa, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangharsha","family":"Thapa","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Chand","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Westchester Medical Center, Valhalla, NY"},{"name":"Department of Medicine, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"R1-20240817","doi-asserted-by":"crossref","first-page":"oeac001","DOI":"10.1093\/ehjopen\/oeac001","article-title":"Endometriosis and cardiovascular disease.","volume":"2","author":"Marchandot","year":"2022","journal-title":"Eur Heart J Open"},{"key":"R2-20240817","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis.","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"R3-20240817","first-page":"3267","article-title":"Defining the genetic profile of endometriosis.","volume":"17","author":"Vassilopoulou","year":"2019","journal-title":"Exp Ther Med"},{"key":"R4-20240817","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(10)60490-4","article-title":"Endometriosis and infertility: pathophysiology and management.","volume":"376","author":"de Ziegler","year":"2010","journal-title":"Lancet"},{"key":"R5-20240817","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.molmed.2018.07.004","article-title":"The immunopathophysiology of endometriosis.","volume":"24","author":"Symons","year":"2018","journal-title":"Trends Mol Med"},{"key":"R6-20240817","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000093121","article-title":"Is endometriosis associated with systemic subclinical inflammation?","volume":"62","author":"Agic","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"R7-20240817","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/humrep\/17.2.426","article-title":"Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial.","volume":"17","author":"Bedaiwy","year":"2002","journal-title":"Hum Reprod"},{"key":"R8-20240817","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.fertnstert.2007.06.019","article-title":"Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain.","volume":"89","author":"Akoum","year":"2008","journal-title":"Fertil Steril"},{"key":"R9-20240817","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5114\/ceji.2015.50840","article-title":"Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.","volume":"40","author":"Malutan","year":"2015","journal-title":"Cent Eur J Immunol"},{"key":"R10-20240817","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1080\/1071576021000049908","article-title":"Atherosclerosis, oxidation and endometriosis.","volume":"36","author":"Santanam","year":"2002","journal-title":"Free Radic Res"},{"key":"R11-20240817","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/humupd\/dmv013","article-title":"Endometriosis: a high-risk population for major chronic diseases?","volume":"21","author":"Kvaskoff","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R12-20240817","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.rbmo.2019.05.021","article-title":"Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance.","volume":"39","author":"Tan","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"R13-20240817","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"key":"R14-20240817","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"Suppl 1","key":"R15-20240817","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1538-7836.2009.03423.x","article-title":"The fate of monocytes in atherosclerosis.","volume":"7","author":"Randolph","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R16-20240817","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"R17-20240817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/3425560","article-title":"Association of inflammatory markers\/cytokines with cardiovascular risk manifestation in patients with endometriosis.","volume":"2021","author":"Rafi","year":"2021","journal-title":"Mediators Inflamm"},{"key":"R18-20240817","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.fertnstert.2009.08.043","article-title":"Unfavorable lipid profile in women with endometriosis.","volume":"93","author":"Melo","year":"2010","journal-title":"Fertil Steril"},{"key":"R19-20240817","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCOUTCOMES.115.002224","article-title":"Endometriosis and risk of coronary heart disease.","volume":"9","author":"Mu","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R20-20240817","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jfma.2020.10.005","article-title":"Risk of major adverse cardiovascular and cerebrovascular events in Taiwanese women with endometriosis.","volume":"120","author":"Chiang","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"R21-20240817","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/1471-0528.16692","article-title":"Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study.","volume":"128","author":"Okoth","year":"2021","journal-title":"BJOG"},{"key":"R22-20240817","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction.","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"R23-20240817","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"R24-20240817","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease.","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"R25-20240817","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genomewide association analysis of coronary artery disease.","volume":"357","author":"Samani","year":"2007","journal-title":"N Engl J Med"},{"key":"R26-20240817","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.","volume":"447","year":"2007","journal-title":"Nature"},{"key":"R27-20240817","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction.","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"key":"R28-20240817","doi-asserted-by":"crossref","first-page":"758440","DOI":"10.3389\/fimmu.2022.758440","article-title":"Genomic evidence supports the recognition of endometriosis as an inflammatory systemic disease and reveals disease-specific therapeutic potentials of targeting neutrophil degranulation.","volume":"13","author":"Bao","year":"2022","journal-title":"Front Immunol"},{"key":"R29-20240817","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.3390\/ijms22147297","article-title":"Genomics of endometriosis: from genome wide association studies to exome sequencing.","volume":"22","author":"Lalami","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R30-20240817","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ng.612","article-title":"A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese.","volume":"42","author":"Uno","year":"2010","journal-title":"Nat Genet"},{"key":"R31-20240817","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.111.085787","article-title":"Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?","volume":"125","author":"Napoli","year":"2012","journal-title":"Circulation"},{"key":"R32-20240817","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fcvm.2018.00145","article-title":"Long noncoding RNA ANRIL: Lnc-ing genetic variation at the chromosome 9p21 locus to molecular mechanisms of atherosclerosis.","volume":"5","author":"Holdt","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"R33-20240817","doi-asserted-by":"crossref","first-page":"102694","DOI":"10.1016\/j.ebiom.2020.102694","article-title":"Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.","volume":"55","author":"Ou","year":"2020","journal-title":"EBioMedicine"},{"key":"R34-20240817","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.fertnstert.2014.07.1237","article-title":"Association of CDKN2B-AS and WNT4 genetic polymorphisms in Korean patients with endometriosis.","volume":"102","author":"Lee","year":"2014","journal-title":"Fertil Steril"},{"key":"R35-20240817","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3892\/ijmm.2023.5232","article-title":"Association of endometriosis with cardiovascular disease: genetic aspects (review).","volume":"51","author":"Vazgiourakis","year":"2023","journal-title":"Int J Mol Med"},{"key":"R36-20240817","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.9778\/cmajo.20220144","article-title":"Endometriosis and cardiovascular disease: a population-based cohort study.","volume":"11","author":"Blom","year":"2023","journal-title":"CMAJ Open"},{"key":"R37-20240817","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejogrb.2006.04.015","article-title":"Atherosclerosis in women with endometriosis.","volume":"132","author":"Pretta","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R38-20240817","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jmig.2019.02.022","article-title":"Link between endometriosis, atherosclerotic cardiovascular disease, and the health of women midlife.","volume":"26","author":"Taskin","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R39-20240817","doi-asserted-by":"crossref","first-page":"e16780","DOI":"10.1371\/journal.pone.0016780","article-title":"NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies.","volume":"6","author":"Garc\u00eda Rodr\u00edguez","year":"2011","journal-title":"PLoS One"},{"key":"R40-20240817","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy.","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"key":"R41-20240817","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/eurheartj\/ehq477","article-title":"Hysterectomy and risk of cardiovascular disease: a population-based cohort study.","volume":"32","author":"Ingelsson","year":"2011","journal-title":"Eur Heart J"},{"key":"R42-20240817","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"},{"key":"R43-20240817","first-page":"747","article-title":"Hysterectomy with and without oophorectomy, tubal ligation, and risk of cardiovascular disease in the nurses\u2019 health study II.","volume":"32","author":"Farland","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"key":"R44-20240817","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/01.CIR.0000159344.21672.FD","article-title":"Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women\u2019s Health Initiative Observational Study.","volume":"111","author":"Howard","year":"2005","journal-title":"Circulation"},{"key":"R45-20240817","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"R46-20240817","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"R47-20240817","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria\u2014a prospective population-based cohort study.","volume":"189","author":"Ollila","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"R48-20240817","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R49-20240817","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS.","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R50-20240817","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"R51-20240817","first-page":"21","article-title":"The relationship between hypertension and anxiety or depression in Hong Kong Chinese.","volume":"10","author":"Cheung","year":"2005","journal-title":"Exp Clin Cardiol"},{"key":"R52-20240817","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/jcm13020483","article-title":"Association of fat mass and skeletal muscle mass with cardiometabolic risk varied in distinct PCOS subtypes: a propensity score-matched case-control study.","volume":"13","author":"Cai","year":"2024","journal-title":"J Clin Med"},{"key":"R53-20240817","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: a northern Finland birth cohort 1966 study.","volume":"104","author":"Ollila","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-20240817","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12020-020-02596-8","article-title":"Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.","volume":"72","author":"Krentowska","year":"2021","journal-title":"Endocrine"},{"key":"R55-20240817","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study.","volume":"106","author":"Berni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20240817","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R57-20240817","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.arcmed.2021.11.001","article-title":"Impact of polycystic ovary syndrome on silent coronary artery disease and cardiovascular events; a long-term population-based cohort study.","volume":"53","author":"Mahboobifard","year":"2022","journal-title":"Arch Med Res"},{"key":"R58-20240817","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2012-1597","article-title":"Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA Women\u2019s Study.","volume":"97","author":"Wang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-20240817","first-page":"44","article-title":"The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.","volume":"15","author":"Demirelli","year":"2015","journal-title":"Bosn J Basic Med Sci"},{"key":"R60-20240817","doi-asserted-by":"crossref","first-page":"806","DOI":"10.36660\/abc.20190762","article-title":"Increased pulmonary arterial stiffness and impaired right ventricle-pulmonary artery coupling in PCOS.","volume":"116","author":"Abacioglu","year":"2021","journal-title":"Arq Bras Cardiol"},{"key":"R61-20240817","first-page":"802","article-title":"Polycystic ovary syndrome triggers atrial conduction disorders: a systematic review and meta-analysis.","volume":"12","author":"Moysidis","year":"2022","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"R62-20240817","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study.","volume":"80","author":"Florido","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R63-20240817","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study.","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"},{"key":"R64-20240817","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R65-20240817","article-title":"Cancer Facts & Figures 2024."},{"key":"R66-20240817","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaccao.2023.02.002","article-title":"Cancer treatment-related cardiovascular toxicity in gynecologic malignancies.","volume":"5","author":"Parashar","year":"2023","journal-title":"JACC CardioOncol"},{"key":"R67-20240817","first-page":"884","article-title":"[Analysis of cardiotoxicity of chemotherapy in 30 cases with gynecological cancer].","volume":"46","author":"Liu","year":"2011","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R68-20240817","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2022.03.025","article-title":"Cardiovascular conditions and obesity among gynecologic cancer survivors: results from the 2020 behavioral risk factor surveillance system survey.","volume":"165","author":"Coughlin","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R69-20240817","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.5114\/amsad\/176655","article-title":"Correlation between gynecological tumors and atherosclerotic diseases.","volume":"8","author":"Mulita","year":"2023","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"R70-20240817","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer.","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"R71-20240817","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2017.11.019","article-title":"The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study.","volume":"148","author":"Kitson","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R72-20240817","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer.","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"R73-20240817","first-page":"1342","article-title":"Long-term cardiovascular outcomes among endometrial cancer survivors in a large, population-based cohort study.","volume":"110","author":"Soisson","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R74-20240817","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.30470","article-title":"High cardiovascular disease mortality after endometrial cancer diagnosis: results from the Surveillance, Epidemiology, and End Results (SEER) Database.","volume":"140","author":"Felix","year":"2017","journal-title":"Int J Cancer"},{"key":"R75-20240817","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/medicina59081476","article-title":"Cardiovascular mortality in ovarian cancer patients","volume":"59","author":"Al-Badawi","year":"2023","journal-title":"Medicina"},{"key":"R76-20240817","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/annonc\/mdn728","article-title":"Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.","volume":"20","author":"Barrett-Lee","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:03:23Z","timestamp":1723914203000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000759","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,30]]}}}